Back to Browse Journals » International Journal of General Medicine » Volume 2

Effects of selective serotonin reuptake inhibitors on motor neuron survival

Authors Lily B Anderson, Phaedra B Anderson, Thea B Anderson, Amy Bishop, et al.

Published Date May 2009 Volume 2009:2 Pages 109—115

DOI http://dx.doi.org/10.2147/IJGM.S4310

Published 28 May 2009

Lily B Anderson1, Phaedra B Anderson1, Thea B Anderson1, Amy Bishop2, James Anderson2

1Cherokee Labsystems, Huntsville, AL USA; 2Department of Biology, University of Alabama in Huntsville, Huntsville, AL, USA

Abstract: Selective serotonin reuptake inhibitors (SSRIs) such as fluoxetine and paroxetine are prescribed to relieve clinical depression and a variety of other disorders. Recently tardive dyskinesia, as well as other movement disorders, have been found to be a clinical side effect of SSRIs. In light of these emerging side effects, we asked if motor neurons were affected by SSRI. Motor neurons were challenged with fluoxetine and paroxetine at clinically relevant doses as well as at lesser and greater doses. Ethanol was used as a negative control and another group of cells was left untreated. As expected, in alcohol-treated cells, there was significant decrease in cell survival and neurite outgrowth. In untreated cells there was no effect in either cell survival or neurite outgrowth. In fluoxetine-treated motor neurons there was ~52% cell death while in paroxetine-treated cells there was 14% cell survival and both SSRIs caused significant loss of the percentage of neurite-bearing cells. Both SSRIs decreased cell survival in a dose-dependent manner. This study is provocative enough to call for further in vivo studies.

Keywords: fluoxetine, paroxetine, motor neurons, NSC34, neurotoxicity, SSRI

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Oncogenic mutation profiling in new lung cancer and mesothelioma cell lines

Lam DC, Luo SY, Deng W, Kwan JS, Rodriguez-Canales J, Cheung AL, Cheng GH, Lin CH, Wistuba II, Sham PC, Wan TS, Tsao SW

OncoTargets and Therapy 2015, 8:195-209

Published Date: 16 January 2015

Enhancement of radiotherapy efficacy by miR-200c-loaded gelatinase-stimuli PEG-Pep-PCL nanoparticles in gastric cancer cells

Cui FB, Liu Q, Li RT, Shen J, Wu PY, Yu LX, Hu WJ, Wu FL, Jiang CP, Yue GF, Qian XP, Jiang XQ, Liu BR

International Journal of Nanomedicine 2014, 9:2345-2358

Published Date: 13 May 2014

Bimatoprost ophthalmic solution 0.03% lowered intraocular pressure of normal-tension glaucoma with minimal adverse events. [Corrigendum]

Tsumura T, Yoshikawa K, Suzumura H, Kimura T, Sasaki S, Kimura I, Takeda R

Clinical Ophthalmology 2013, 7:129-130

Published Date: 16 January 2013

Corneal topographic changes following trans-conjunctival 20 gauge sutureless vitrectomy (TC20V)

Abdel Alim Mohamed A, Abdrabbo M

Clinical Ophthalmology 2012, 6:565-569

Published Date: 24 April 2012

Comparison of the effect between pegaptanib and ranibizumab on exudative age-related macular degeneration with small lesion size

Nishimura Y, Taguchi M, Nagai T, Fujihara M, Honda S, Uenishi M

Clinical Ophthalmology 2012, 6:365-368

Published Date: 6 March 2012

Further data on the association between Helicobacter pylori infection and primary open-angle glaucoma

Zavos C, Kountouras J

Clinical Ophthalmology 2012, 6:243-245

Published Date: 10 February 2012

Corrigendum: Softec HD hydrophilic acrylic intraocular lens: biocompatibility and precision

Espandar L, Sikder S, Moshirfar M

Clinical Ophthalmology 2011, 5:159-160

Published Date: 6 February 2011